PlainRecalls
FDA Drug Moderate Class II Ongoing

Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41

Reported: April 16, 2025 Initiated: March 21, 2025 #D-0356-2025

Product Description

Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Details

Units Affected
4956 vials
Distribution
U.S. Nationwide
Location
Bengaluru, N/A

Frequently Asked Questions

What product was recalled?
Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41. Recalled by Somerset Therapeutics Private Limited. Units affected: 4956 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Media fill with bacterial contamination
Which agency issued this recall?
This recall was issued by the FDA Drug on April 16, 2025. Severity: Moderate. Recall number: D-0356-2025.